The discussion dives into the complex relationship between pharma and data utilization, highlighting the challenges of selling to the pharmaceutical industry. Insights reveal how real-world patient demographics often differ significantly from those in clinical trials, impacting drug efficacy and application. The conversation also touches on the financial intricacies of developing a sustainable business model in a changing economic landscape.
